Dulaglutide CAS 879600-73-4
879600-73-4
Pharmaceutical Grade
99%
shanghai
Mobelbiochem
1-100g in bottles
2023-12-28
Peptide supplements,Cosmetic peptides,Cosmetic raw materials,Peptide
-
Product Description
-
Seller Information
-
DescriptionECHEMI Editorial ReferenceDulaglutide is a once-weekly, GLP-1 receptor agonist, consisting of a DPP-IV-protected GLP-1 analogue covalently linked to a human IgG4-Fc heavy chain by a small peptide linker,thereby protecting the GLP-1 moiety from inactivation by dipeptidyl peptidase.Basic Info
-
Product Name:
Dulaglutide
Other Name:N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-(furan-2-yl)imidazo[1,2-a]pyridin-3-amine;Imidazo[1,2-a]pyridin-3-amine, N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-(2-furanyl)-
CAS No.:879600-73-4
Molecular Formula:C19H15N3O3
Molecular Weight:333.34
Categories:
Characteristics-
Density:
1.41±0.1 g/cm3(Predicted)
PKA:6.89±0.50(Predicted)
Research-
Class:
GLP-1 receptor agonist (GLP-1 analog fused to human IgG4-Fc, long-acting)
Status:FDA-approved (Trulicity 2014)
Mechanism:A long-acting GLP-1 receptor agonist consisting of a modified human GLP-1 molecule (7-37) covalently linked to a modified human IgG4 Fc fragment via a small peptide linker. The Fc fusion extends the half-life to ~5 days, allowing once-weekly dosing. Activates GLP-1R to enhance glucose-dependent insulin secretion, suppress glucagon, and slow gastric emptying.
Activity note:Dulaglutide is a dual-agonist with GLP-1R activation. The exact EC50 is proprietary; functional potency is comparable to other long-acting GLP-1R agonists.
Source:DrugBank: DB09095; PubChem CID 16135271.
Clinical Development:FDA:Trulicity (approved 2014-09-18)
References-
DrugBank:PubChem:Disclaimer:
Dulaglutide is FDA-approved as a prescription medicine (Trulicity) for type 2 diabetes. This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Peptide supplements,Cosmetic peptides,Cosmetic raw materials,Peptide
-
Location:
25 No.Bio-chemicals Technical Zoon,Yuhang District, Hangzhou city,Zhejiang P.R China
-
Payment Terms:
TT against copy of documents,L/C,TT against B/L draft before shipment,100% TT in advance
-
Average lead Time:
10
-
Total Annual Revenue:
$10 million-$25 million
-
Total Employees:
51-100
-
Year of Establishment:
2020
-
Certifications:
cqc,ISO
-
-
Country Product Purchase Quantity Date Posted Post an enquiry for this product
